Alfred Marotti, MD
Surgery · Little Rock, ARNPI 1154373728
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 32.3% of the total. That places this record below the midpoint for surgery clinicians in AR, where the typical reported total is $1,616.
Across 67 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$466
- TAS Medical, Inc.$282
- TELA Bio, Inc.$117
- Acera Surgical, Inc.$98
- AstraZeneca$75
- Medtronic$61
- plus $347 from 13 others
What the payments were for
- Food & beverage$1,445100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 29 | $466 |
| TAS Medical, Inc. | 4 | $282 |
| TELA Bio, Inc. | 3 | $117 |
| Acera Surgical, Inc. | 5 | $98 |
| AstraZeneca(2 entities) | 4 | $75 |
| Medtronic | 2 | $61 |
| Johnson & Johnson | 3 | $55 |
| Kerecis Limited | 3 | $48 |
| Innocoll Pharmaceuticals Limited | 3 | $37 |
| Myriad Genetic Laboratories, Inc. | 2 | $36 |
| Davol Inc. | 1 | $35 |
| Lemaitre Vascular, Inc. | 1 | $26 |
| Solventum Corporation | 1 | $19 |
| Stryker | 1 | $19 |
| Portola Pharmaceuticals, LLC | 1 | $18 |
| Olympus America Inc. | 1 | $15 |
| Misonix Inc | 1 | $15 |
| Merck | 1 | $13 |
| Acell, Inc. | 1 | $12 |
How this compares
$1,445 in reported general payments places this provider in the 45th percentile of 227 surgery providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 83 | $346 |
| Tamsulosin Hcl | 22 | $89 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $70 |
| Tramadol Hcl | 29 | $43 |
| Ondansetron Hcl | 25 | $43 |
Paid to pharmacies, not to this prescriber.
Other surgery in Little Rock
- Samuel BledsoeLittle Rock$53K
- Michael PollockLittle Rock$45K
- James WalkerLittle Rock$41K
- Eric PaulLittle Rock$22K
- Peter KimLittle Rock$20K
- April TurnerLittle Rock$9K
- Raj PatelLittle Rock$8K
- Bobby PerryLittle Rock$7K
- Joshua RollerFayetteville$248K
- Alice CherquiJonesboro$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.